Sonata Therapeutics News and Activities

Sonata Therapeutics is owned by Flagship Pioneering.

Flagship Pioneering has 3 subsidiaries including Etiome, Pioneering Medicines and Sonata Therapeutics.

They are in:

• Biotechnology75%
• Fund25%

View the org chart displaying its 12 main executives

Most searched biographies at Sonata Therapeutics

• Volker Herrmann, Chief Executive Officer and President
• David Khougazian, Chairman of the Board
• Michael Rosenblatt, Director

Popular executive movements at Flagship Pioneering

• John Cuozzo has joined the company as Senior Vice President, Head of Research  (posted on November 19 2025).
• Yvonne Hao has joined the company as Chief Operating Officer and General Partner  (posted on September 23 2025).
• Mary Harler has joined the company as President of Pioneering Medicines  (posted on September 23 2025).

Create your alert
to follow the executive moves at Sonata Therapeutics.

Flagship Pioneering has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Sonata Therapeutics

Social media about Sonata Therapeutics

• Sonata Therapeutics on Wikipedia, Google News & Yahoo Finance
• Sonata Therapeutics on LinkedIn, X (Twitter) & YouTube